Literature DB >> 30613614

Ebola virus and persistent chronic infection: when does replication cease?

John V Forrester1,2.   

Abstract

Entities:  

Year:  2018        PMID: 30613614      PMCID: PMC6291550          DOI: 10.21037/atm.2018.09.60

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  23 in total

1.  C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans.

Authors:  Carmen P Alvarez; Fátima Lasala; Jaime Carrillo; Oscar Muñiz; Angel L Corbí; Rafael Delgado
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

2.  How Ebola virus infects cells.

Authors:  Yoshihiro Kawaoka
Journal:  N Engl J Med       Date:  2005-06-23       Impact factor: 91.245

3.  The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus.

Authors:  Catherine L Hunt; Andrey A Kolokoltsov; Robert A Davey; Wendy Maury
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

Review 4.  Tissue-based class control: the other side of tolerance.

Authors:  Polly Matzinger; Tirumalai Kamala
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

5.  Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses.

Authors:  Mansour Mohamadzadeh; Sadie S Coberley; Gene G Olinger; Warren V Kalina; Gordon Ruthel; Claudette L Fuller; Dana L Swenson; William D Pratt; Douglas B Kuhns; Alan L Schmaljohn
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation.

Authors:  Benjamin Yen; Lubbertus C F Mulder; Osvaldo Martinez; Christopher F Basler
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

7.  T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus.

Authors:  Andrew S Kondratowicz; Nicholas J Lennemann; Patrick L Sinn; Robert A Davey; Catherine L Hunt; Sven Moller-Tank; David K Meyerholz; Paul Rennert; Robert F Mullins; Melinda Brindley; Lindsay M Sandersfeld; Kathrina Quinn; Melodie Weller; Paul B McCray; John Chiorini; Wendy Maury
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-02       Impact factor: 11.205

Review 8.  Dendritic cell physiology and function in the eye.

Authors:  John V Forrester; Heping Xu; Lucia Kuffová; Andrew D Dick; Paul G McMenamin
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

9.  Tyro3 family-mediated cell entry of Ebola and Marburg viruses.

Authors:  Masayuki Shimojima; Ayato Takada; Hideki Ebihara; Gabriele Neumann; Kouki Fujioka; Tatsuro Irimura; Steven Jones; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

10.  Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro.

Authors:  Manisha Gupta; Christina Spiropoulou; Pierre E Rollin
Journal:  Virology       Date:  2007-03-27       Impact factor: 3.616

View more
  5 in total

1.  Expression of microRNA in human retinal pigment epithelial cells following infection with Zaire ebolavirus.

Authors:  Genevieve F Oliver; Ayla V Orang; Binoy Appukuttan; Shashikanth Marri; Michael Z Michael; Glenn A Marsh; Justine R Smith
Journal:  BMC Res Notes       Date:  2019-10-01

Review 2.  Immune Privilege: The Microbiome and Uveitis.

Authors:  Christine Mölzer; Jarmila Heissigerova; Heather M Wilson; Lucia Kuffova; John V Forrester
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

3.  Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in Nigeria.

Authors:  Anise N Happi; Testimony J Olumade; Olusola A Ogunsanya; Ayotunde E Sijuwola; Seto C Ogunleye; Judith U Oguzie; Cecilia Nwofoke; Chinedu A Ugwu; Samuel J Okoro; Patricia I Otuh; Louis N Ngele; Oluwafemi O Ojo; Ademola Adelabu; Roseline F Adeleye; Nicholas E Oyejide; Clinton S Njaka; Jonathan L Heeney; Christian T Happi
Journal:  Microbiol Spectr       Date:  2022-08-01

4.  AAV-monoclonal antibody expression protects mice from Ebola virus without impeding the endogenous antibody response to heterologous challenge.

Authors:  Laura P van Lieshout; Amira D Rghei; Wenguang Cao; Shihua He; Geoff Soule; Wenjun Zhu; Sylvia P Thomas; Debra Sorensen; Kathy Frost; Kevin Tierney; Brad Thompson; Stephanie Booth; David Safronetz; Raveendra R Kulkarni; Byram W Bridle; Xiangguo Qiu; Logan Banadyga; Sarah K Wootton
Journal:  Mol Ther Methods Clin Dev       Date:  2022-08-12       Impact factor: 5.849

5.  On the whereabouts of SARS-CoV-2 in the human body: A systematic review.

Authors:  Wim Trypsteen; Jolien Van Cleemput; Willem van Snippenberg; Sarah Gerlo; Linos Vandekerckhove
Journal:  PLoS Pathog       Date:  2020-10-30       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.